U.S. Stem Cell, Inc logo — company profile

U.S. Stem Cell, Inc

Founded 1999 United States Sunrise, United States 13 employees Post Ipo Debt Biotechnology, Health Care

General Information

Company Name U.S. Stem Cell, Inc
Founded Year 1999
Location United States Sunrise, United States +1
Employees 13
Industries Biotechnology, Health Care
Funding Stage Post Ipo Debt
Social

Get notified when U.S. Stem Cell, Inc moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About U.S. Stem Cell, Inc

U.S. Stem Cell, Inc. is a leader in regenerative medicine and is committed to providing autologous cell therapies for the treatment of degenerative conditions. The company specializes in the development of proprietary, physician-based stem cell therapies; novel regenerative solutions, including its lead product AdipoCell™; physician training and certification; veterinary applications; stem cell banking; as well as creating and managing new stem cell clinics. In the past 20 years, to the company’s knowledge, U.S. Stem Cell, Inc. has completed more clinical treatments than any other regenerative care provider in the world. With more than 700 physicians trained and certified with the company, U.S. Stem Cell, Inc. boasts the largest network of physicians working together to continue its mission of harnessing the body’s own ability to heal from within to treat a wide variety of conditions and to improve quality of life. The company was founded in 1999 and operates in the industries of Biotechnology and Health Care. It is headquartered in the United States. As of now, there is no information available regarding the last investment and the investors involved in the latest investment round for U.S. Stem Cell, Inc.

No funding data available for U.S. Stem Cell, Inc yet.

Get notified when U.S. Stem Cell, Inc raises funding

U.S. Stem Cell, Inc Alternatives & Competitors

U.S. Stem Cell, Inc vs

To Make Regenerative Medicine a Reality for Patients Around the World

23 employees
Biotechnology
U.S. Stem Cell, Inc vs
Gallant
Gallant United States

Restoring Health. Redefining Veterinary Care. Off-the-shelf stem cell therapies that target the root...

Seed
67 employees
Biotechnology, Health and Wellness
U.S. Stem Cell, Inc vs

ISCI: Leading in regenerative medicine with advanced stem cell therapies to improve health and quali...

Seed
2 employees
Biotechnology

FAQ About U.S. Stem Cell, Inc

U.S. Stem Cell, Inc. is a leader in regenerative medicine and is committed to providing autologous cell therapies for the treatment of degenerative conditions. The company specializes in the development of proprietary, physician-based stem cell therapies; novel regenerative solutions, including its...
U.S. Stem Cell, Inc was founded in 1999.
U.S. Stem Cell, Inc is headquartered in Sunrise, United States.
U.S. Stem Cell, Inc operates in the following industries: Biotechnology, Health Care.
U.S. Stem Cell, Inc has approximately 13 employees.
Top alternatives and competitors to U.S. Stem Cell, Inc include Global Stem Cells Group, Gallant, The International Stem Cell Institute, StemSave, Inc. , Creative Medical Technology Holdings Inc. (Nasdaq: CELZ). These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
U.S. Stem Cell, Inc and Global Stem Cells Group are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors U.S. Stem Cell, Inc and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

One analytics cookie (Google Analytics). Cookie Policy